Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22563494 | 0.97 | CYP1A2 (0.40) | CYP1A2CYP2C9CYP2C19NPSR1ABCG2 | |
| SCHEMBL23487650 | 0.95 | MAOA (0.33) | CYP1A2CYP2C9CYP2C19NPSR1ABCG2 | |
| SCHEMBL23487699 | 0.94 | ABCG2 (0.37) | ABCG2 | |
| SCHEMBL23487348 | 0.94 | ABCG2 (0.40) | CYP1A2CYP2C9CYP2C19NPSR1ABCG2 | |
| SCHEMBL23487723 | 0.94 | CYP1A2 (0.40) | CYP1A2CYP2C9CYP2C19NPSR1ABCG2 | |
| SCHEMBL23487356 | 0.93 | AR (0.37) | CYP1A2CYP2C9CYP2C19NPSR1ABCG2 | |
| SCHEMBL23487237 | 0.92 | ABCG2 (0.41) | CYP1A2CYP2C9CYP2C19ABCG2ALDH1A1 | |
| SCHEMBL23487749 | 0.92 | GRIN1 (0.33) | CYP1A2CYP2C9CYP2C19NPSR1ABCG2 | |
| SCHEMBL21108805 | 0.91 | CYP1A2 (0.38) | CYP1A2CYP2C9CYP2C19NPSR1ALDH1A1 | |
| SCHEMBL22563704 | 0.91 | CYP1A2 (0.41) | CYP1A2CYP2C9CYP2C19NPSR1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | CYP1A2 600/4885CYP2C9 336/4885CYP2C19 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.